Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Dimitrov

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Scientific Reports|April 19, 2018
Projected effectiveness and added value of HIV vaccination campaigns in South Africa: A modeling studySimon de Montigny, Blythe J S Adamson, Benoît R Mâsse, et al.
Journal of Virology|August 1, 1996
The adenovirus E3-14.7K protein and the E3-10.4K/14.5K complex of proteins, which independently inhibit tumor necrosis factor (TNF)-induced apoptosis, also independently inhibit TNF-induced release of arachidonic acidP Krajcsi, T Dimitrov, T W Hermiston, et al.
Plos One|July 9, 2016
How Much Do We Know about Drug Resistance Due to PrEP Use? Analysis of Experts' Opinion and Its Influence on the Projected Public Health ImpactDobromir T Dimitrov, Marie-Claude Boily, Timothy B Hallett, et al.
Vaccine|March 21, 2019
Targeting and vaccine durability are key for population-level impact and cost-effectiveness of a pox-protein HIV vaccine regimen in South AfricaChristian Selinger, Anna Bershteyn, Dobromir T Dimitrov, et al.
Nature|May 16, 1998
Forced degradation of Fas inhibits apoptosis in adenovirus-infected cellsA E Tollefson, T W Hermiston, D L Lichtenstein, et al.
Lancet Regional Health. Americas|February 27, 2023
Estimating the impact of HIV PrEP regimens containing long-acting injectable cabotegravir or daily oral tenofovir disoproxil fumarate/emtricitabine among men who have sex with men in the United States: a mathematical modelling study for HPTN 083Kate M Mitchell, Marie-Claude Boily, Brett Hanscom, et al.
Plos Neglected Tropical Diseases|October 10, 2018
The impact and cost-effectiveness of controlling cholera through the use of oral cholera vaccines in urban Bangladesh: A disease modeling and economic analysisAshraful Islam Khan, Ann Levin, Dennis L Chao, et al.
Journal of the International AIDS Society|January 19, 2026
Cost-effectiveness of leveraging long-acting injectable cabotegravir to expand PrEP coverage among MSM in two contrasting North American citiesJesse A Heitner, Sarah E Stansfield, Kate M Mitchell, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|May 9, 2020
Receptive anal sex contributes substantially to heterosexually acquired HIV infections among at-risk women in twenty US cities: Results from a modelling analysisJocelyn Elmes, Romain Silhol, Kristen L Hess, et al.
Journal of the International AIDS Society|July 13, 2023
Population-level impact of expanding PrEP coverage by offering long-acting injectable PrEP to MSM in three high-resource settings: a model comparison analysisSarah E Stansfield, Jesse Heitner, Kate M Mitchell, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Scientific Reports|April 19, 2018
Projected effectiveness and added value of HIV vaccination campaigns in South Africa: A modeling studySimon de Montigny, Blythe J S Adamson, Benoît R Mâsse, et al.
Journal of Virology|August 1, 1996
The adenovirus E3-14.7K protein and the E3-10.4K/14.5K complex of proteins, which independently inhibit tumor necrosis factor (TNF)-induced apoptosis, also independently inhibit TNF-induced release of arachidonic acidP Krajcsi, T Dimitrov, T W Hermiston, et al.
Plos One|July 9, 2016
How Much Do We Know about Drug Resistance Due to PrEP Use? Analysis of Experts' Opinion and Its Influence on the Projected Public Health ImpactDobromir T Dimitrov, Marie-Claude Boily, Timothy B Hallett, et al.
Vaccine|March 21, 2019
Targeting and vaccine durability are key for population-level impact and cost-effectiveness of a pox-protein HIV vaccine regimen in South AfricaChristian Selinger, Anna Bershteyn, Dobromir T Dimitrov, et al.
Nature|May 16, 1998
Forced degradation of Fas inhibits apoptosis in adenovirus-infected cellsA E Tollefson, T W Hermiston, D L Lichtenstein, et al.
Lancet Regional Health. Americas|February 27, 2023
Estimating the impact of HIV PrEP regimens containing long-acting injectable cabotegravir or daily oral tenofovir disoproxil fumarate/emtricitabine among men who have sex with men in the United States: a mathematical modelling study for HPTN 083Kate M Mitchell, Marie-Claude Boily, Brett Hanscom, et al.
Plos Neglected Tropical Diseases|October 10, 2018
The impact and cost-effectiveness of controlling cholera through the use of oral cholera vaccines in urban Bangladesh: A disease modeling and economic analysisAshraful Islam Khan, Ann Levin, Dennis L Chao, et al.
Journal of the International AIDS Society|January 19, 2026
Cost-effectiveness of leveraging long-acting injectable cabotegravir to expand PrEP coverage among MSM in two contrasting North American citiesJesse A Heitner, Sarah E Stansfield, Kate M Mitchell, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|May 9, 2020
Receptive anal sex contributes substantially to heterosexually acquired HIV infections among at-risk women in twenty US cities: Results from a modelling analysisJocelyn Elmes, Romain Silhol, Kristen L Hess, et al.
Journal of the International AIDS Society|July 13, 2023
Population-level impact of expanding PrEP coverage by offering long-acting injectable PrEP to MSM in three high-resource settings: a model comparison analysisSarah E Stansfield, Jesse Heitner, Kate M Mitchell, et al.
Pageof 8